CCO Official Conference Coverage: Clinical Impact of New HIV Data From AIDS 2022 *

July 29-August 2, 2022; Montreal, Quebec
Engage in this scientific analysis of data presented at AIDS 2022, with rapid postconference webinars by expert faculty and Capsule Summaries on key HIV prevention, treatment studies,and new and investigational ART regimens. Watch the on-demand webinars, download the slides, and gain global perspectives with companion ClinicalThought commentaries.

Share

Program Content

10 Capsule Summary Slidesets

Activities

HPTN 083: Results in TGW
HPTN 083: Safety, Efficacy, and Gender-Affirming Hormonal Therapy Interactions With Long-Acting Injectable CAB for HIV PrEP in Transgender Women
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 01, 2022

Expires: July 31, 2023

NAMSAL Wk 192 Results
NAMSAL: Wk 192 Results of Dolutegravir-Based vs Low-Dose Efavirenz-Based Regimens as First-line ART in Cameroon
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 02, 2022

Expires: August 01, 2023

SIMPL’HIV Wk 144
SIMPL’HIV Wk 144 Results: Dolutegravir + Emtricitabine vs Standard Combination ART for Maintenance of Virologic Suppression
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 02, 2022

Expires: August 01, 2023

ALLIANCE Study Results
ALLIANCE: Phase III Randomized Controlled Trial of BIC/FTC/TAF vs DTG + FTC/TDF in Treatment-Naive Adults With HIV/HBV Coinfection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 03, 2022

Expires: August 02, 2023

ANDES
ANDES: Generic Fixed-Dose DRV/RTV in Combination With 3TC vs 3TC/TDF for Initial HIV Treatment
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

TB-PRACTECAL
TB-PRACTECAL: Efficacy and Safety of Three 24-Wk Oral Regimens for Pulmonary Rifampicin-Resistant TB in Persons With HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

6-Mo PrEP + HIVST
Effect of 6-Mo PrEP Dispensing Plus HIV Self-Testing on 12-Mo PrEP Continuation
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

VRC01 in Infants
IMPAACT 2008: Broadly Neutralizing Antibody VRC01 Plus ART in Infants With HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

DoxyPEP: Doxycycline STI PEP
DoxyPEP: Prevention of STIs With Doxycycline PEP Among MSM and TGW With HIV or Receiving PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

HPTN 084: CAB in Cisgender Women
HPTN 084 Update: Long-Acting Injectable CAB vs Daily Oral TDF/FTC for HIV PrEP in Cisgender Women
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 03, 2022

Expires: August 02, 2023

Activities

Preview: AIDS 2022
My Take on the Most Outstanding Presentations at AIDS 2022
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 13, 2022

Expires: July 12, 2023

Review: AIDS 2022
HIV Prevention and Treatment Data From AIDS 2022
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 23, 2022

Expires: August 22, 2023

Slides: AIDS 2022
Key HIV Studies Influencing My Practice Following AIDS 2022
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2022

Expires: August 16, 2023

Audio Recap: AIDS 2022
Key HIV Studies Influencing My Practice Following AIDS 2022—Audio Redcap
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 04, 2022

Expires: October 03, 2023

Activities

TDF vs TAF in HIV/HBV
BIC/FTC/TAF vs DTG + FTC/TDF in Persons With HIV and HBV Coinfection: The Story So Far
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 19, 2022

Expires: August 18, 2023

Asia-Pacific Perspective
My Choice of AIDS 2022 Studies Most Relevant for Physicians in the Asia-Pacific Region
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2022

Expires: September 15, 2023

Faculty

cover img faculity

Chien-Ching Hung, MD, PhD

Professor
Attending Physician
Department of Internal Medicine
National Taiwan University Hospital
Taiwan

cover img faculity

Daniel R. Kuritzkes, MD

Director of AIDS Research
Brigham & Womens Hospital
Professor of Medicine
Harvard Medical School
Partners AIDS Research Center
Boston, Massachusetts

cover img faculity

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, Doherty Institute
Melbourne Laureate Professor
Director, Cumming Global Centre for Pandemic Therapeutics
Head, Department of Infectious Diseases
The University of Melbourne
Melbourne, Australia

cover img faculity

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities 
Dean for Healthcare Transformation
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

cover img faculity

Jürgen Rockstroh, MD

Professor of Medicine
Head of Infectious Diseases
Department of Medicine I
University Hospital Bonn
Bonn, Germany

cover img faculity

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

cover img faculity

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.